Day: May 10, 2022

Posted on

Reuters Partners with The Globe and Mail’s Sophi.io Automation Platform

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) — Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail, is now working with Reuters – the news and media division of Thomson Reuters – as it continues to invest in the latest AI solutions for its newsroom. Sophi is helping to automate content curation on select sections on Reuters.com, which was relaunched in April 2021.

Sophi Site Automation is an AI system that autonomously curates digital content to find and promote an organization’s most engaging content. Sophi looks at all content as it’s published, and all traffic, to find the hidden gems that an organization’s customers value the most.

In order to automate content curation, Sophi’s algorithm has been learning from Reuters editors. The newsroom has been able to work with some of the latest AI solutions, which has resulted in giving time back to editors to focus on finding the next story and creating the journalism that makes Reuters such a trusted brand.

Josh London, Head of Reuters Professional and Chief Marketing Officer of Reuters, said: “Sophi’s cutting-edge AI platform is one of the next steps in the evolution of our digital properties. Sophi will help us further our mission of bringing AI-based technology and tools to more corners of the workforce, whilst helping to bring our readers the stories they both want and need to know.”

Michael Young, Chief Technology Officer for Reuters, said: “Our partnership with Sophi.io is another example of how a newsroom like ours can successfully deploy some of the latest AI solutions for effective content discovery. Our team worked closely with the Sophi team to ensure our Sophi Score reflected our business goals and we are pleased with the resulting site automation.”

Mike O’Neill, Co-Founder and CEO of Sophi.io, added “We are delighted to have Reuters as a customer. They put their trust in Sophi and we are excited to automate curation across all of their article pages to start and expand the relationship to include more solutions down the road.”

“It’s wonderful to work with Reuters in this capacity,” said Phillip Crawley, Publisher and CEO of The Globe and Mail. “They have a strong mission and Sophi.io is helping them continue to demonstrate how editorial integrity can be supported by AI.”

About Reuters
Reuters is the world’s leading provider of trusted news, insight and analysis, reaching billions of people worldwide every day. Founded in 1851, it brings together world-class journalism, industry expertise and cutting-edge technology with unparalleled speed, reliability and accuracy to enable people to make better decisions. Reuters is committed to the Trust Principles of independence, integrity and freedom from bias, and is the essential source of business, financial and world news delivered to financial professionals exclusively via Refinitiv services, and to the world’s media organizations, industry events and directly to consumers.

About Sophi.io
Sophi.io (https://www.sophi.io) was developed by The Globe and Mail to help content publishers make important strategic and tactical decisions. It is a suite of AI and ML-powered automation, optimization and prediction solutions that include Sophi Site Automation, Sophi for Paywalls and Sophi for First Party Data. Sophi also powers one-click automated laydown of template-free print publishing. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Contact us
Kayley Rogers
Communications Manager
Reuters
Kayley.rogers@thomsonreuters.com

Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail        
jrubenovitch@globeandmail.com
416-585-3355
Posted on

Taconic Biosciences Appoints Nomura Siam as Distributor in India for All Taconic Animal Models

Improves Access to Critical Rodent Models for Researchers in India

RENSSELAER, N.Y., May 10, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd (NSI), an established distributor of laboratory animals and related products, as its preferred distributor in India.

India makes a significant contribution to global pharmaceutical and vaccine production, and its pharmaceutical and biotechnology research and development is expected to grow over the next decade. To support this growth, scientists in India need advanced mouse and rat models for pharmacology studies and toxicology and drug safety assessment. Research across all therapeutic areas requires genetically engineered models (GEMs). Additionally, mice with humanized immune systems are critical for immuno-oncology and other applications.

Taconic’s portfolio comprises nearly 4,700 mouse and rat models, including widely used standard strains, immunodeficient models, and exclusive GEMs. Taconic is also a global leader in humanized immune system mouse generation. Taconic’s industry-leading quality systems, genetic integrity, and globally harmonized animal health standards promote research reproducibility while its flexible approach to licensing reduces barriers to accessing valuable GEMs.

Based in Thailand, NSI is known for its focus on quality and customer service. The company’s new agreement with Taconic significantly increases preclinical researchers’ access to GEMs in India and allows NSI to offer this market a full spectrum of solutions.

“To date, rodent model selection and availability has been somewhat limited in India. We believe this partnership will provide India’s growing pharmaceutical industry access to the most sophisticated and high-quality animal models available globally,” said Dr. Michael Seiler, vice president of commercial products at Taconic. “We truly believe this partnership will support Taconic’s desire to accelerate new life-saving therapeutics for the global community.”

“Taconic’s portfolio of sophisticated mouse models fills a major gap in the Indian market,” said Taiichiro Kamiya, president of NSI. “By our frequent information sharing, and the improvement of logistic process, we will provide faster and easier access to GEMs for Indian users.”

To learn more about Taconic’s full line of animal model solutions, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the US and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

About Nomura Siam International Co. Ltd. (NSI)

Nomura Siam International Co. Ltd., based in Bangkok, Thailand, was jointly established in 2012 by CLEA Japan, Inc. and Nomura Jimusho, Inc. as a comprehensive provider for the laboratory animal field. As a one-stop service supplier, NSI not only sells laboratory animals but also handles a wide range of related products, including equipment for breeding, conducting experiments, and environmental enrichment, as well as consulting services for preclinical research and laboratory animal facility design.

Media Contact:

Aidan Bouchelle
Associate Director, Marketing Operations
518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Taconic Biosciences Nomeia Nomura Siam como Distribuidora para Todos os Modelos Animais da Taconic na Índia

Acesso aprimorado aos modelos críticos de roedores para pesquisadores na Índia

RENSSELAER, NY, May 10, 2022 (GLOBE NEWSWIRE) — A Taconic Biosciences, líder global no fornecimento de soluções de modelo de animais para a descoberta de medicamentos, anunciou a nomeação da Nomura Siam International Co., Ltd. (NSI), distribuidora de animais de laboratório e produtos afins, como sua distribuidora preferida na Índia.

A Índia contribui significativamente para a produção global de produtos farmacêuticos e vacinas, e a sua investigação e desenvolvimento farmacêuticos e biotecnológicos devem crescer ao longo da próxima década. Para apoiar esse crescimento, os cientistas na Índia precisam de modelos avançados de camundongos e ratos para estudos de farmacologia e toxicologia e avaliação da segurança dos medicamentos. A pesquisa em todas as áreas terapêuticas requer modelos geneticamente modificados (GEMs). Além disso, camundongos com sistemas imunológicos humanizados são essenciais para a imuno-oncologia e outras aplicações.

O portfólio da Taconic abrange quase 4.700 modelos de camundongos e ratos, incluindo cepas padrão amplamente usadas, modelos imunodeficientes e GEMs exclusivas. A Taconic também é líder global na geração de camundongos com sistema imunológico humanizado. Os sistemas de qualidade líderes, a integridade genética e os padrões de saúde animal harmonizados em todo o mundo da indústria da Taconic, promovem a reprodutibilidade da pesquisa, enquanto sua abordagem flexível ao licenciamento reduz as barreiras ao acesso aos GEMs valiosos.

Com sede na Tailândia, a NSI é conhecida pelo seu foco na qualidade e atendimento ao cliente. O novo acordo da empresa com a Taconic aumenta significativamente o acesso de pesquisadores pré-clínicos aos GEMs na Índia e permite que a NSI ofereça a este mercado um espectro completo de soluções.

“Até agora a seleção e a disponibilidade de modelos de roedores têm sido um pouco limitadas na Índia. Acreditamos que esta parceria fornecerá à indústria farmacêutica da Índia crescente acesso aos modelos animais mais sofisticados e de alta qualidade disponíveis em todo o mundo”, disse o Dr. Michael Seiler, vice-presidente de produtos comerciais da Taconic. “Nós realmente acreditamos que esta parceria apoiará o desejo da Taconic de acelerar novas terapêuticas que salvam vidas para a comunidade global.”

“O portfólio da Taconic de modelos sofisticados de camundongos preenche uma grande lacuna no mercado na Índia”, disse Taiichiro Kamiya, presidente da NSI. “Com o nosso compartilhamento frequente de informações e a melhoria do processo logístico, forneceremos acesso mais rápido e fácil às GEMs para os usuários indianos.”

Para mais informações sobre a linha soluções de modelo de animais da Taconic, ligue para 1-888-TACONIC (888- 822- 6642) nos EUA, +45 70 23 04 05 na Europa, ou envie email para info@taconic.com.

Sobre a Taconic Biosciences, Inc.

A Taconic Biosciences é uma líder global totalmente licenciada em serviços e modelos geneticamente modificados. Fundada em 1952, a Taconic oferece as melhores soluções/modelos de pesquisas em murinos, para que os clientes possam adquirir, customizar, criar, pré-condicionar, testar e distribuir valiosos modelos de pesquisa em todo o mundo. Especializada em modelos de camundongos e de ratos geneticamente projetados, microbioma, modelos de camundongos imuno-oncologia, e serviços de design e criação de modelos integrados, a Taconic opera laboratórios de serviços e instalações de criação nos EUA e na Europa, mantém relações com distribuidores na Ásia , e tem capacidades de entrega em nível global para oferecer modelos em quase qualquer lugar no mundo.

Sobre a Nomura Siam International Co. Ltd. (NSI)

A Nomura Siam International Co. Ltd., com sede em Bangkok, Tailândia, foi criada em 2012 pela CLEA Japan, Inc. juntamente com a Nomura Jimusho, Inc. como fornecedora abrangente para o campo de animais de laboratório. Como fornecedora completa de serviços únicos, a NSI, além de vender animais de laboratório, também lida com uma ampla gama de produtos afins, incluindo equipamentos para criação de animais e experimentos, enriquecimento ambiental, bem como fornece serviços de consultoria para pesquisa pré-clínica e instalações de projetos com animais de laboratório.

Contato com a Mídia:

Aidan Bouchelle
Diretor Associado, Operações de Marketing
518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Taconic Biosciences nomme Nomura Siam comme distributeur en Inde pour tous les modèles animaux Taconic

Amélioration de l’accès aux modèles de rongeurs critiques pour les chercheurs en Inde

RENSSELAER, New York, 10 mai 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, l’un des leaders mondiaux des solutions de modèles animaux pour la mise au point de médicaments, a nommé Nomura Siam International Co., Ltd (NSI), distributeur établi d’animaux de laboratoire et de produits connexes, comme son distributeur privilégié en Inde.

L’Inde apporte une contribution significative à la production mondiale de produits pharmaceutiques et de vaccins, et sa recherche et son développement pharmaceutiques et biotechnologiques devraient connaître une réelle croissance au cours de la prochaine décennie. Afin de soutenir celle-ci, les scientifiques indiens ont besoin de modèles avancés de souris et de rats pour les études pharmacologiques et l’évaluation de la toxicologie et de l’innocuité des médicaments. La recherche dans tous les domaines thérapeutiques nécessite des modèles génétiquement modifiés (MGM). En outre, les souris dotées de systèmes immunitaires humanisés sont essentielles pour l’immuno-oncologie et d’autres applications.

Le portefeuille de Taconic comprend près de 4 700 modèles de souris et de rats, y compris des souches standard largement utilisées, des modèles immunodéficients et des MGM exclusifs. Taconic est également un leader mondial de la génération de souris à système immunitaire humanisé. Les systèmes de qualité, l’intégrité génétique et les normes de santé animale harmonisées à l’échelle mondiale leaders du secteur de Taconic favorisent la reproductibilité des études, tandis que son approche flexible des licences réduit les obstacles à l’accès à de précieux MGM.

Basée en Thaïlande, NSI est connue pour son accent mis sur la qualité et le service à la clientèle. Le nouvel accord de la société avec Taconic augmente considérablement l’accès aux MGM pour les chercheurs précliniques en Inde et permet à NSI d’offrir à ce marché une gamme complète de solutions.

« À ce jour, la sélection et la disponibilité des modèles de rongeurs ont été quelque peu limitées en Inde. Nous sommes convaincus que ce partenariat fournira à l’industrie pharmaceutique indienne en plein croissance un accès aux modèles animaux les plus sophistiqués et de haute qualité disponibles à l’échelle mondiale », a déclaré le Dr Michael Seiler, vice-président des produits commerciaux chez Taconic. « Nous sommes vraiment convaincus que ce partenariat aidera Taconic dans son désir d’accélérer de nouveaux traitements vitaux pour la communauté mondiale. »

« Le portefeuille de modèles de souris sophistiqués de Taconic comble une lacune majeure sur le marché indien », a commenté Taiichiro Kamiya, président de NSI. « Grâce à notre partage fréquent d’informations et à l’amélioration du processus logistique, nous fournirons aux utilisateurs indiens un accès plus rapide et plus facile aux MGM. »

Pour en savoir plus sur la gamme complète de solutions de modèles animaux de Taconic, veuillez composer le 1-888-TACONIC (888-822-6642) aux États-Unis, le +45 70 23 04 05 en Europe, ou envoyer un e-mail à l’adresse info@taconic.com.

À propos de Taconic Biosciences, Inc.

Taconic Biosciences est un leader mondial pleinement agréé dans les modèles et les services de rongeurs génétiquement modifiés. Fondée en 1952, Taconic offre les meilleures solutions animales afin que les clients puissent acquérir, générer d’une manière personnalisée, élever, pré-conditionner, tester et distribuer des modèles de recherche précieux dans le monde entier. Spécialiste des modèles de souris et de rats génétiquement modifiés, du microbiome, des modèles de souris pour l’immuno-oncologie et des services de conception de modèles intégrés et d’élevage, Taconic exploite des laboratoires de services et des établissements d’élevage aux États-Unis et en Europe, entretient des relations de distribution en Asie et dispose de capacités d’expédition mondiales pour fournir des modèles animaux presque partout dans le monde.

À propos de Nomura Siam International Co. Ltd. (NSI)

Nomura Siam International Co. Ltd., entreprise sis à Bangkok (Thaïlande), a été créée conjointement en 2012 par CLEA Japan, Inc. et Nomura Jimusho, Inc. en tant que fournisseur exhaustif dans le domaine des animaux de laboratoire. En tant que prestataire de services unifiés, NSI commercialise non seulement des animaux de laboratoire, mais gère également une vaste gamme de produits connexes, y compris des équipements destinés à l’élevage, à la réalisation d’expériences et à l’enrichissement environnemental, ainsi que des services de conseil en matière de recherche préclinique et la conception de sites pour animaux de laboratoire.

Contact auprès des médias :

Aidan Bouchelle
Directeur associé en charge des opérations marketing
518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Procter & Gamble announces new commitments and shares progress on actions to strengthen Equality & Inclusion across Asia Pacific, the Middle-East, and Africa

The commitments were announced at the P&G #WeSeeEqual regional summit that saw participation from global equality and inclusion advocates like Simone Biles, Dr.  Nawal Al Hosany, Anita Bhatia, Valerie Jarrett, among others

SINGAPORE, May 10, 2022 /PRNewswire/ — Procter & Gamble (NYSE:PG) today announced new commitments aimed toward advancing Equality & Inclusion across Asia Pacific, the Middle East, and Africa, at its fourth annual #WeSeeEqual summit for the region. The event saw participation from distinguished advocates and personalities from the private and public sectors who came together to discuss the challenges that society faces on equality and inclusion, and how different stakeholders can accelerate progress in the new normal.

Built on the theme, ‘#Unlearn and #Unleash‘, the summit saw P&G commit to several actions needed to advance progress towards creating an equal and inclusive world. P&G President for Asia Pacific, Middle East, and Africa, Magesvaran Suranjan, announced the following commitments:

  • P&G will spend a cumulative total of $300 million US dollars by deliberately working with women-owned and women-led businesses across the Asia Pacific, Middle East, and Africa region, from the year 2021 to 2025.
    • Last year, P&G committed to spending a cumulative total of $200 million US dollars by deliberately working with women-owned and women-led businesses across the region, from the year 2021 to 2025. With already more than $100 million US dollars invested through this initiative in the first year across the AMA region, the company is now elevating this commitment to $300 million US dollars by 2025.
  • P&G will achieve equal representation of female directors behind the camera for the company’s brand advertisements in Asia Pacific, Middle East, and Africa, by 2024.
    • In the AMA region, P&G has made strong progress, increasing representation of female directors from 16% in 2019 to 35% today. The company will achieve the 50-50 goal by 2024 through a comprehensive set of actions to build, fuel, and connect a pipeline of diverse female talent in advertising, media, and content.
  • P&G will improve the accessibility of its brand advertising, including social media content and websites, by making it accessible to people with sight and hearing impairments by 2024.
    • The company will do this for all new brand advertising across Asia Pacific, the Middle East, and Africa. This initiative will make P&G brands more inclusive and accessible to all members of our community.
  • P&G will introduce the ‘P&G ReLaunch program’ – to welcome back talented professionals who took a break from the workforce and are looking to restart their careers in STEM roles, with targeted support and development.
    • This program is part of the company’s commitment to strengthen diversity in STEM (Science, Technology, Engineering and Mathematics) and will focus on people looking to relaunch their careers in IT, Research & Development, and Product Supply. The program will be first launched in India, Egypt, Singapore, Japan, and the Philippines.

Magesvaran Suranjan said: “At P&G, we remain fully committed to creating a world where equal access and opportunity to learn, grow, succeed, and thrive are available to everyone. We believe in the power of our differences and the impact we can make when we come together, united by our shared values and purpose. We are making great progress, yet we know there is more work to be done. So we are announcing bold new commitments and expanding existing actions which will enable us to do more. We will continue to use the voice of our company and our brands in forums such as #WeSeeEqual to drive discussion and actions on the issues that matter.”

The company also shared strong progress on commitments across the Asia Pacific, Middle East, and Africa region made last year as part of the annual #WeSeeEqual summit. In 2021, P&G announced its ‘Share the Care’ parental leave policy, which has introduced greater leave benefits and flexibility for all new parents within the company. P&G has also achieved its commitment to achieving a 50-50 gender balance across its management workforce by 2022 in the AMA region, completing this ahead of schedule. On its commitment to educate more than 30 million girls on puberty and hygiene by 2024, through its brands Always and Whisper‘s “Keeping Girls in School” program, the company has already reached more than 15 million girls, achieving the halfway mark in one year.

Held in partnership with UN Women, the fourth annual regional #WeSeeEqual Summit engaged business leaders, government officials, and personalities in candid conversations around strategic actions that can be taken to advance equality and inclusion.

In addition to global and regional P&G leaders, the Summit also saw the participation of influential personalities and global leaders, including:

  • Simone Biles, the world’s most decorated gymnast
  • Valerie Jarrett, Chief Executive Officer, The Barack Obama Foundation
  • Her Excellency Dr. Nawal Al Hosany, UAE’s permanent representative to the International Renewable Energy Agency (IRENA)
  • Anita Bhatia, Assistant Secretary-General and Deputy Executive Director, UN Women
  • Alma Har’el, award-winning director, founder of Free the Bid and FREE THE WORK
  • Dr. Hsien Hsien Lei, Chief Executive Officer, The American Chamber of Commerce, Singapore
  • Scott Beaumont, President, Google – Asia Pacific
  • Lillian Barnard, Chief Executive Officer, Microsoft – South Africa

To inspire corporates and society alike, the summit also hosted P&G’s Chief Operating Officer, Shailesh Jejurikar, and the company’s Chief Brand Officer, Marc Pritchard to share their experiences and insights on the importance of leadership to drive equality and redefine inclusion behind the camera.

The #WeSeeEqual program demonstrates P&G’s continued commitment to creating a more equal and inclusive world and is also a winner of the U.S. Secretary of State’s Award for Corporate Excellence for Women’s Empowerment in 2019. As one of the world’s largest advertisers, P&G and its brands will also continue to leverage their influential voice in media and advertising to drive further awareness, tackle gender bias, spark conversations, and motivate change.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

Photo – https://mma.prnewswire.com/media/1814474/WSE_2022_KV_FINAL_1.jpg
Logo – https://mma.prnewswire.com/media/1571597/Procter_and_Gamble_logo.jpg

Posted on

Huawei OceanStor Distributed Storage Is Named as a 2022 Gartner Peer Insights Customers’ Choice for Distributed File Systems and Object Storage

SHENZHEN, China, May 10, 2022 /PRNewswire/ — Gartner Peer Insights recognized Huawei OceanStor distributed storage as a Customers’ Choice in the 2022 Gartner Peer Insights ‘Voice of the Customer’: Distributed File Systems and Object Storage report. Scoring 4.9 out of 5 points on the annual Gartner Peer Insights platform, Huawei OceanStor distributed storage ranked first among all global vendors.

Gartner Peer Insights is an online ratings and reviews platform for IT software and services. The reviews are written and read by IT professionals and technology decision-makers worldwide. It includes more than 380,000 verified reviews from end-users who have experience purchasing, implementing, or using products or services in over 360 markets. Each year, vendors with high customer ratings are named a Gartner Peer Insights Customers’ Choice, helping IT leaders make more informed purchasing decisions.

As of January 31, 2022, Huawei OceanStor distributed storage products and solutions had received many positive reviews from customers around the world and in various industries, such as finance, carrier, manufacturing, energy, media, healthcare, and education. These reviews cover everything from system architecture, product functionality, and deployment to O&M, service, and support. All of these highlight how global customers think of Huawei OceanStor distributed storage in terms of industry position, deployment scale, and commercial use maturity.

“We are very grateful for our customers sharing their opinions on Gartner Peer Insights. Our only goal is to provide solutions and products that make our customers happy,” Mr. Wang Yidong, President of Huawei Distributed Storage Domain, said, “We will continue to focus on our customers’ needs and keep providing efficient and reliable distributed storage products and solutions to safeguard innovative services in each and every industry.”

Confirming this customer focus, one industry architect commented, “We are deeply impressed by the customer-centric working attitude of Huawei engineers. The product itself is very responsive, easy to use for unstructured data, and highly scalable.”

“We need a new type of storage to replace the traditional centralized storage. After POC test, we found that the reliability and scalability of Huawei distributed storage can be realized. The storage capacity can be expanded quickly and the management interface functions are complete,” wrote one IT technical director in the finance industry.

A review from a CTO in the manufacturing sector stated, “Huawei is experienced on distributed storage product. The storage is stable with different networks. And I do like the unified platform idea.”

Specially designed to accommodate mass data, Huawei OceanStor distributed storage provides diversified storage services for high-performance computing (HPC), big data analytics, video, content repository/backup and archiving, virtualization, and cloud resource pools. It helps enterprises fully unleash the value of mass data.

Photo – https://mma.prnewswire.com/media/1814234/image_1.jpg

Posted on

Hitachi Energy launches game-changing power semiconductor module globally for all types of electric vehicles

High-performance power electronics take e-mobility to the next level and advance a more sustainable energy future for all

Zurich, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) — Hitachi Energy, the global technology and market leader in power grids, today announced it will launch globally RoadPak, its pioneering power semiconductor module for electric vehicles at PCIM Europe, the world’s leading power electronics trade fair in Nuremberg, Germany, May 10-12.

RoadPak sets a new benchmark in electric vehicle performance. This compact module uses state-of-the-art silicon carbide (SiC) technology to achieve exceptional levels of power density for faster charging, reliability over the vehicle’s lifetime, and the lowest possible power losses for the longest possible driving range.

“RoadPak is the result of more than 100 years of Hitachi Energy innovation and market leadership in power electronics,” said Niklas Persson, Managing Director of Hitachi Energy’s Grid Integration business. “Along with our Grid-eMotion™ Flash and Fleet EV charging systems, it builds on our commitment to take e-mobility to the next level and advance a more sustainable energy future for all.”

Tested by many EV manufacturers and with two seasons of flawless performance with the Mahindra Racing Formula E team, RoadPak is available in both the 750 volt and 1,200 volt ranges. This makes it ideal for all types of electric vehicle – regular and luxury cars, commercial vehicles, buses, agricultural EVs, heavy-duty trucks and high-performance racing cars.

“We have had the privilege of piloting this advanced power module on our Mahindra M7Electro and M8Electro racing cars over the last two years, which has proven to significantly increase performance and reliability,” said Dilbagh Gill, CEO and Team Principal of Mahindra Racing. “This high technology improvement allows us to develop next-generation state-of-the-art green automotive solutions and improve driving experience.”

Power semiconductors are a critical component in electric vehicles. They are the heart of the inverter, which converts DC power from the vehicle’s battery into the AC power that drives the motor. Reliability is key. RoadPak semiconductors are designed to operate faultlessly for more than four million start-stop cycles over the vehicle’s lifetime.

The EV market is growing exponentially. Global sales of electric cars grew 40 percent in 2020 and almost doubled in 2021.1 In addition, all major car manufacturers have committed to phase out their petrol and diesel vehicles by 2030 or earlier.

Hitachi Energy has two separate manufacturing sources supporting security of supply worldwide for its SiC-based power semiconductor products, including RoadPak. The company makes its own SiC chips at its semiconductor factory in Switzerland and is supported by an independent SiC chip manufacturer in the United States, thereby securing supply in terms of both volumes and geographic availability.

Hitachi Energy’s advanced semiconductor technology is a key component in its grid integration solutions that enable vast amounts of renewable energy to flow reliably through power grids and between nations. They are also key to the traction converter systems that drive high-speed electric trains and metros, and the electric vehicles that are making road transportation clean and sustainable.

Notes to the Editor:

1. According to the International Energy Agency and World Economic Forum respectively: https://www.iea.org/news/global-electric-car-sales-set-for-further-strong-growth-after-40-rise-in-2020 and https://www.weforum.org/agenda/2022/02/electric-cars-sales-evs/.

About Hitachi Energy Ltd.

Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. We are advancing the world’s energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. Headquartered in Switzerland, we employ around 38,000 people in 90 countries and generate business volumes of approximately $10 billion USD.

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company’s consolidated revenues for fiscal year 2021 (ended March 31, 2022) totaled 10,264.6 billions of yen (84,136 millions of U.S. dollars), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.

Attachments

Rebecca Bleasdale
Hitachi Energy Ltd.
+41 78643 2613
rebecca.bleasdale@hitachienergy.com
Posted on

Nyxoah Reports First Quarter 2022 Financial and Operating Results

REGULATED INFORMATION

Nyxoah Reports First Quarter 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium – May 10, 2022, 08:50pm CET / 2:50pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the first quarter of 2022.

First Quarter 2022 Financial and Operating Highlights

  • Generated revenue of €660,000 from the commercialization of Genio® in Europe, primarily in Germany, which represents year-over-year growth of more than three-and-and-half times and is more than double what was achieved in the fourth quarter of 2021
  • Exited the first quarter with 15 active implant sites in Germany, representing 25% growth over Q4 2021; Nyxoah expects to add an extra 10 sites by the end of the third quarter of 2022, bringing the total to 25 active implanting accounts and driving quarterly sales acceleration and market leadership in Germany by the end of 2022
  • Completed the first commercial Complete Concentric Collapse (CCC) patients in Germany
  • Accelerated monthly patient enrollment in the DREAM U.S. IDE study and continue to expect implants to be completed in the second quarter of 2022
  • The U.S. FDA approved Nyxoah’s request to reduce the sample size in DREAM to 115 patients from the original 134, driven by new and favorable data from the BETTER SLEEP study; aside from the updated sample size, all other study parameters, including performance goals, statistical power, and significance level, remain identical to the original approved study
  • Nominated Raymond Cohen, Chief Executive Officer and board member of Axonics, Inc. and Virginia Kirby, Executive-in-Residence at the Discovery Launchpad at the University of Minnesota’s Office of Technology Commercialization, for appointment to the Board of Directors, pending approval by the Annual Shareholders’ Meeting on June 8, 2022; Don Deyo and Jan Janssen are stepping down, keeping the total number of board members at eight

“I am extremely pleased with our first quarter results and strong execution that resulted in an acceleration in sales and DREAM implants as we progress towards achieving all of our strategic priorities for 2022 and beyond,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “On the commercial side, the €660,000 of revenue we booked in the first quarter was roughly equal to the revenue performance from the previous three quarters combined. We now have 15 active implant sites in Germany, and we will continue to add 10 more sites by the end of the third quarter. This growth validates our patient-centric, ‘Going Deep’ strategy of developing Centers of Excellence as we increase therapy penetration at each of these sites. We were also thrilled to implant our first commercial CCC patients in Germany, and we expect continued acceleration in CCC implants following the positive response to our BETTER SLEEP data presentation at the World Sleep Congress in Rome, where we hosted 55 key opinion leaders during the pre-Congress symposium.”

Mr. Taelman continued, “We are also happy with the acceleration in the pace of implants in our DREAM U.S. pivotal study, given recent weekly implant rates, which have increased meaningfully over the last month. We believe we have enough patients enrolled to complete the study by the end of the second quarter of 2022, particularly in light of the FDA’s approval to reduce the sample size to 115 patients. We also continue our dialogue with FDA regarding our IDE submission for our ACCCESS trial for CCC patients in the U.S., and we expect to implant our first patient before the end of this year.”

“Finally, I am thrilled to announce the nominations of Ray Cohen and Ginny Kirby for appointment to the Board of Directors. They will bring a wealth of knowledge that will benefit Nyxoah as we complete DREAM, prepare for our U.S. launch, and advance our pipeline. I look forward to working closely with both of them,” concluded Mr. Taelman.

First Quarter 2022 Results

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS AT AND FOR THE THREE MONTHS ENDED MARCH 31, 2022 – INTERIM CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS (IN THOUSANDS)

        For the three months ended March 31
Notes 2022   2021
       
Revenue €  660 €  185
Cost of goods sold   ( 289) ( 52)
Gross profit €  371 €  133
Research and Development Expense   (3 595) (3 094)
Selling, General and Administrative Expense (4 193) (2 366)
Other income/(expense) 136 4
Operating loss for the period   € (7 281) € (5 323)
Financial income 1 576 4
Financial expense   ( 788) ( 325)
Loss for the period before taxes € (6 493) € (5 644)
Income taxes   ( 208) ( 25)
Loss for the period € (6 701) € (5 669)
     
Loss attributable to equity holders € (6 701) € (5 669)
Other comprehensive loss  
Items that may be subsequently reclassified to profit or loss (net of tax)
Currency translation differences   ( 102) ( 70)
Total comprehensive loss for the year, net of tax € (6 803) € (5 739)
Loss attributable to equity holders   € (6 803) € (5 739)
Basic Loss Per Share (in EUR) € (0.260) € (0.256)
Diluted Loss Per Share (in EUR) € (0.260) € (0.256)

The accompanying notes are an integral part of these condensed consolidated interim financial statements

 

UNAUDITED CONSOLIDATED BALANCESHEET (in thousands)

        As at
March 31 2022   December 31 2021
ASSETS
Non-current assets        
Property, plant and equipment € 2 048 € 2 020
Intangible assets 28 526   25 322
Right of use assets 3 154 3 218
Deferred tax asset     529   46
Other long-term receivables 165 164
    € 34 422   € 30 770
Current assets      
Inventory     301   346
Trade receivables 619 226
Other receivables     1 607   2 286
Other current assets 1 197 1 693
Financial assets 45 041 −
Cash and cash equivalents 82 787 135 509
  € 131 552 € 140 060
Total assets € 165 974 € 170 830
   
EQUITY AND LIABILITIES
Capital and reserves    
Capital 4 432 4 427
Share premium 228 158   228 033
Share based payment reserve   3 788 3 127
Other comprehensive income 100   202
Retained loss   (93 864) (87 167)
Total equity attributable to shareholders € 142 614 € 148 622
     
LIABILITIES
Non-current liabilities    
Financial debt 7 952   7 802
Lease liability   2 664 2 737
Pension liability 80   80
Provisions   22 12
Deferred tax liability −   5
€ 10 718 € 10 636
Current liabilities    
Financial debt 598   554
Lease liability   599 582
Trade payables 3 401   3 995
Current tax liability 3 588   2 808
Other payables 4 456   3 633
  € 12 642 € 11 572
Total liabilities € 23 360 € 22 208
Total equity and liabilities € 165 974 € 170 830

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS AT AND FOR THE THREE MONTHS ENDED MARCH 31, 2022 – INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (IN THOUSANDS)

        For the three months ended March 31
2022   2021
CASH FLOWS FROM OPERATING ACTIVITIES
Loss before tax for the year       € (6 493)   € (5 644)
Adjustments for
Finance income (1 576) ( 4)
Finance expenses 788 325
Depreciation and impairment of property, plant and equipment and right-of-use assets 255 164
Amortization of intangible assets 208 211
Share-based payment transaction expense 665 −
Increase/(decrease) in provisions 10 −
Other non-cash items 180 3
Cash generated before changes in working capital € (5 963) € (4 945)
Changes in working capital
Decrease/(Increase) in inventory 45 ( 51)
(Increase)/decrease in trade and other receivables 884 (1 195)
Increase/(Decrease) in trade and other payables ( 392) 2 170
Cash generated from changes in operations € (5 426) € (4 021)
Interests received − 1
Income tax paid (65) (34)
Net cash used in operating activities € (5 491) € (4 054)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment ( 128) ( 169)
Capitalization of intangible assets (3 412) (1 606)
(Increase)/decrease in financial assets – current (44 032) −
Net cash used in investing activities € (47 572) € (1 775)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of principal portion of lease liabilities ( 146) ( 135)
Repayment of other loan ( 21) ( 21)
Interests paid ( 109) ( 105)
Proceeds from issuance of shares, net of transaction costs 130 52
Other financial costs (2) −
Net cash generated from financing activities € ( 148) € ( 209)
Movement in cash and cash equivalents € (53 211) € (6 038)
Effect of exchange rates on cash and cash equivalents 489 ( 55)
Cash and cash equivalents at January 1 € 135 509 € 92 300
Cash and cash equivalents at March 31 € 82 787 € 86 207

Revenue

Revenue was €660,000 for the first quarter ending March 31, 2022, compared to €185,000 for the first quarter ending March 31, 2021. The increase in revenue was attributable to the Company’s commercialization of the Genio® system, primarily in Germany.

Cost of Goods Sold

Cost of goods sold was €289,000 for the three months ending March 31, 2022, representing a gross profit of €371,000, or gross margin of 56.2%.

Research and Development Expenses

Research and Development expenses were €3.6 million for the three months ending March 31, 2022, versus €3.1 million for the prior year period, reflecting the Company’s investments in the development of next generation versions of the Genio® system as well as ongoing clinical studies, most notably DREAM in the U.S.

Selling, General and Administrative Expenses

General and administrative expenses rose to €4.2 million for the first quarter of 2022, up from €2.4 million in the first quarter of 2021. This was due primarily to increased commercial efforts in Germany and other European markets, as well as investments in Nyxoah’s corporate infrastructure. The Company expects to continue adding headcount across the organization ahead of U.S. commercial launch.

Operating Loss

Total operating loss for the first quarter of 2022 was €7.3 million versus €5.3 million in the first quarter of 2021, driven by the acceleration in our R&D spending, as well as ongoing commercial and clinical activities. Nyxoah realized a net loss of €6.7 million for the quarter ended March 31, 2022, compared to a net loss of €5.7 million for the quarter ended March 31, 2021.

Cash Position
As of March 31, 2022, cash and financial assets totaled €127.8 million on March 31, 2022, compared to €135.5 million on December 31, 2021. Total cash burn was approximately €2.6 million per month during the first quarter of 2022. Nyxoah expects monthly cash burn to increase slightly as the year progresses to account for the commencement of the ACCCESS IDE trial in the U.S., and current cash position provides ample liquidity to get to U.S. commercialization in 2024.

First Quarter 2022 Report
Nyxoah’s financial report for the first quarter of 2022, including details of the consolidated results, are available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).

Conference call and webcast presentation 
Nyxoah will conduct a conference call open to the public tomorrow, May 10, 2022, at 2:00 p.m. CET / 8:00 a.m. ET, which will also be webcasted. To participate in the conference call, please dial one of the following numbers:

Conference ID: 8444917

USA:                             (844) 260-3718
Belgium:                       0800 73264
International:                (929) 517-0938

A question-and-answer session will follow the presentation of the results. To access the live webcast, go to https://investors.nyxoah.com/events. The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements 
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2021, to be filed with the Securities and Exchange Commission (“SEC”) on March 24, 2022, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment

Posted on

LeddarTech Releases Its LeddarSteer Automotive-Grade, Solid-State Digital Beam Steering Technology for LiDAR Sensor Developers

LeddarSteer DBS

LeddarSteer DBS by LeddarTech

QUEBEC, May 10, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce the official release of LeddarSteer™, a digital beam steering solution designed for LiDAR smart sensor developers and Tier 1-2 automotive suppliers.

Digital beam steering refers to changing the direction of laser pulses in a LiDAR. Using a stack of alternating liquid crystal cells and polarization gratings enables to steer light at different angles at a specific wavelength in order to augment a LiDAR field of view while maximizing its performance, allowing digital beam steering for LiDAR to be achieved.

LeddarSteer digital beam steering offers a myriad of benefits to LiDAR smart sensor developers and Tier 1 and 2 customers, including:

  • Software-controlled on-the-fly adjustment
    • Frame-by-frame adjustment
    • Preset or customized configuration
    • Easy setup and interface
    • Voltage-controlled steering
  • Multiple LiDAR applications
    • Compatible with a wide range of LiDAR architectures
    • Enables one LiDAR to address multiple use cases
    • Field of view adjustable for various actions, including turns, exits, lane changes and slopes
    • Same LiDAR for highway and city driving
    • Reduces the number of sensors, generating cost savings
  • Automotive-grade solid-state technology, resulting in a significantly higher MTBF (mean time between failures)

LeddarSteer can be seamlessly integrated into an existing LiDAR to expand the field of view or integrated into new LiDAR development. The solution provides an enhanced signal-to-noise ratio by concentrating laser power on a small region of interest while reducing the size, cost and complexity of LiDAR components whilst maintaining or increasing the pixel count and resolution.

“For well over a decade, LeddarTech has been a leader in developing sensing solutions that enable our customers to deliver high-performance ADAS and AD sensors,” stated Mr. Charles Boulanger, CEO of LeddarTech. “LeddarSteer is the only digital beam steering smart component designed for mass production with the flexibility, reliability, cost, size and performance required by the most demanding 3D sensing applications and supported by standard automotive manufacturing process,” concluded Mr. Boulanger.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LeddarEngine™, which is built on LeddarTech’s Leddar™ technology employing patented signal acquisition and processing techniques to generate a richer and cleaner return signal at a lower cost. The LeddarEngine comprises a highly integrated, scalable LiDAR SoC and software combination that enables LiDAR developers and Tier 1-2 automotive suppliers to design their own LiDAR solutions. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 120 patents granted or applied for, enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/75f154a6-27b8-4546-8614-00d3885feef0

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/95010106-6e76-4996-ac0a-3c68c7c09d3d


Copyright © 2022 GlobeNewswire, Inc.

Posted on

LeddarTech lance LeddarSteer, la technologie solid-state d’orientation numérique du faisceau de classe automobile pour les développeurs de capteurs LiDAR

LeddarSteer DBS

LeddarSteer DBS par LeddarTech

QUÉBEC, 10 mai 2022 (GLOBE NEWSWIRE) — LeddarTech®, chef de file de calibre mondial en technologie de détection précise, robuste et polyvalente pour les systèmes avancés d’aide à la conduite (systèmes ADAS) et de conduite autonome (systèmes AD), est heureuse d’annoncer le lancement officiel de LeddarSteer™, une solution d’orientation numérique du faisceau conçue pour les développeurs de capteurs LiDAR intelligents et les fournisseurs automobiles de rang 1-2.

La technologie d’orientation numérique du faisceau fait référence au changement de direction des impulsions laser dans un LiDAR. L’utilisation d’une superposition de cellules à cristaux liquides alternées et de réseaux de polarisation permet de diriger la lumière à différents angles et à une longueur d’onde spécifique afin d’augmenter le champ de vision d’un LiDAR tout en maximisant sa performance, assurant ainsi l’orientation numérique du faisceau LiDAR.

La solution d’orientation numérique du faisceau LeddarSteer offre un très grand nombre d’avantages aux développeurs de capteurs LiDAR intelligents et aux fournisseurs de rang 1-2, dont :

  • Ajustements instantanés commandés par logiciel
    • Ajustement image par image
    • Configuration prédéfinie ou personnalisée
    • Mise en œuvre aisée et interface conviviale
    • Commande par variation de tension
  • Multiples applications LiDAR
    • Compatible avec une grande variété d’architectures LiDAR
    • Permet de couvrir de multiples cas d’utilisation
    • Champ de vision réglable pour diverses actions, y compris les tournants, les sorties, les changements de voie et les déclivités
    • Même LiDAR pour la conduite sur autoroute ou urbaine
    • Réduit le nombre de capteurs, donc les coûts
  • Technologie solid-state de qualité automobile, pour une fiabilité nettement accrue

Le LeddarSteer peut parfaitement être intégré dans une architecture LiDAR existante afin d’élargir le champ de vision, ou être intégré dans un nouveau système. La solution améliore le rapport signal sur bruit en concentrant la puissance laser sur une région d’intérêt précise, tout en réduisant la taille, le coût et la complexité des composants LiDAR et en conservant une haute résolution.

« Depuis plus d’une décennie, LeddarTech est à l’avant-scène dans le développement de solutions de détection qui permettent à nos clients de fournir des capteurs ADAS et AD à haute performance », a déclaré M. Charles Boulanger, chef de la direction de LeddarTech. « LeddarSteer est le seul composant intelligent d’orientation numérique du faisceau conçu pour la production de masse conforme aux exigences d’agilité, de fiabilité, de coût, de taille et de performance requises par les applications de détection 3D les plus strictes et compatible avec les processus standard de fabrication automobiles », a conclu M. Boulanger.

À propos de LeddarTech

Fondée en 2007, LeddarTech propose des solutions de détection environnementale exhaustives et intégrées qui permettent à ses clients de résoudre des problèmes critiques en matière de détection, de fusion de données et de perception tout au long de la chaîne de valeur. LeddarTech offre des solutions de perception optimisées et évolutives appuyant les niveaux d’autonomie 2 (aide à la conduite) jusqu’à 5 (autonomie complète) avec LeddarVision™, une plateforme de fusion de données brutes de capteurs et de perception qui génère un modèle environnemental 3D détaillé à partir d’une variété de configurations et de types de capteurs. LeddarTech soutient également les fabricants de LiDARs et les fournisseurs automobiles de rang 1 et 2 en proposant des blocs technologiques clés comme l’orientation numérique du faisceau LeddarSteer™ ou le LeddarEngine™, bâti sur la technologie Leddar™ de LeddarTech et qui recourt à des techniques d’acquisition et de traitement de signal brevetées pour générer un signal de retour plus riche et plus net à moindre coût. Le LeddarEngine est une combinaison SoC et logicielle LiDAR évolutive hautement intégrée qui permet aux développeurs de LiDARs et aux fournisseurs automobiles de rang 1-2 de concevoir leurs propres solutions LiDAR. Détentrice de plus de 120 brevets accordés ou en instance, la société a contribué à plusieurs innovations liées à des applications de télédétection de pointe destinées au marché automobile et de la mobilité et qui améliorent les capacités des systèmes d’aide à la conduite et de conduite autonome.

Renseignements complémentaires disponibles sur www.leddartech.com et sur LinkedIn, Twitter, Facebook et YouTube.

Contact :
Daniel Aitken, vice-président, Marketing, communications et relations avec les investisseurs mondiaux, LeddarTech Inc.
Tél. : + 1-418-653-9000 poste 232 daniel.aitken@leddartech.com

Contact relations investisseurs : InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator et les logos associés sont des marques de commerce ou des marques déposées de LeddarTech Inc. et de ses filiales. Tous les autres noms de marques, noms de produits et marques sont ou peuvent être des marques de commerce ou des marques déposées utilisées pour désigner les produits ou les services de leurs propriétaires respectifs.

Une photo accompagnant ce communiqué de presse est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/75f154a6-27b8-4546-8614-00d3885feef0/fr

Une vidéo accompagnant ce communiqué est disponible à : https://www.globenewswire.com/NewsRoom/AttachmentNg/95010106-6e76-4996-ac0a-3c68c7c09d3d/fr

Proudly powered by WordPress